{"componentChunkName":"component---src-templates-tag-template-js","path":"/author/koh-xh","result":{"data":{"site":{"siteMetadata":{"title":"Bioinformatics Institute Publications","subtitle":"Repository of all published Science Articles by our Researchers, their Group Members and Collaborators."}},"allMarkdownRemark":{"edges":[{"node":{"fields":{"slug":"/posts/2020-01-07-therapeutic-anti-cancer-activity-of-antibodies-targeting-sulfhydryl-bond-constrained-epitopes-on-unglycosylated-ron-receptor-tyrosine-kinase/"},"frontmatter":{"title":"Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase","date":"2019-08-15T07:18:57.773Z","categories":["Atomistic Simulations and Design in Biology","Biomolecular Modelling and Design Division"],"description":"Recepteur dâ€™origine nantais (RON) receptor tyrosine kinase (RTK) and its ligand, serum macrophage-stimulating protein (MSP), are well-established oncogenic drivers for tumorigenesis and metastasis. RON is often found to be alternatively spliced resulting in various isoforms that are constitutively active. RON is therefore an attractive target for cancer therapeutics, including small molecular inhibitors and monoclonal antibodies. "}}}]}},"pageContext":{"tag":"Koh XH","currentPage":0,"postsLimit":8,"postsOffset":0,"prevPagePath":"/author/koh-xh","nextPagePath":"/author/koh-xh/page/1","hasPrevPage":false,"hasNextPage":false}}}